These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 15315518

  • 1. The role of treatment to increase HDL-cholesterol and decrease triglyceride concentrations in prevention of coronary heart disease in Type 2 diabetes.
    Wild S, Byrne CD.
    Diabet Med; 2004 Sep; 21 Suppl 4():8-11. PubMed ID: 15315518
    [No Abstract] [Full Text] [Related]

  • 2. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [Abstract] [Full Text] [Related]

  • 3. A case report of a diabetic woman with very low HDL cholesterol.
    Chaychi L, Kinlaw WB, Asztalos BF, Schaefer EJ.
    J Clin Lipidol; 2010 Apr; 4(2):133-5. PubMed ID: 21122641
    [No Abstract] [Full Text] [Related]

  • 4. Choice of lipid-regulating drugs.
    Med Lett Drugs Ther; 2001 May 28; 43(1105):43-8. PubMed ID: 11378632
    [No Abstract] [Full Text] [Related]

  • 5. Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control.
    Hobbs FD.
    Int J Cardiol; 2006 Jun 16; 110(2):137-45. PubMed ID: 16289373
    [Abstract] [Full Text] [Related]

  • 6. Diabetic dyslipidemia: a practical guide to therapy.
    Tovar JM, Bazaldua OV, Loffredo A.
    J Fam Pract; 2008 Jun 16; 57(6):377-88. PubMed ID: 18544321
    [Abstract] [Full Text] [Related]

  • 7. What is the most effective strategy for managing diabetic dyslipidaemia?
    Reasner CA.
    Atheroscler Suppl; 2005 Sep 16; 6(3):21-7. PubMed ID: 16054442
    [Abstract] [Full Text] [Related]

  • 8. Nicotinic acid and HDL-C reduction.
    S Afr Med J; 2005 Feb 16; 95(2):89. PubMed ID: 15751197
    [No Abstract] [Full Text] [Related]

  • 9. Dyslipidaemia in diabetic patients: time for a rethink.
    Shepherd J.
    Diabetes Obes Metab; 2007 Sep 16; 9(5):609-16. PubMed ID: 17697054
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective.
    Roze S, Ferrières J, Bruckert E, Van Ganse E, Chapman MJ, Liens D, Renaudin C.
    Int J Clin Pract; 2007 Nov 16; 61(11):1805-11. PubMed ID: 17850322
    [Abstract] [Full Text] [Related]

  • 11. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.
    Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D.
    Diabetes Care; 2006 Jun 16; 29(6):1220-6. PubMed ID: 16731999
    [Abstract] [Full Text] [Related]

  • 12. Modifying plasma low-density lipoprotein and high-density lipoprotein cholesterol: what combinations are available in the future?
    Kastelein JJ.
    Am J Cardiol; 2005 Nov 07; 96(9A):20K-27K; discussion 34K-35K. PubMed ID: 16291010
    [Abstract] [Full Text] [Related]

  • 13. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M.
    Dtsch Med Wochenschr; 2009 May 07; 134(20):1067-73. PubMed ID: 19421932
    [Abstract] [Full Text] [Related]

  • 14. [Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
    März W.
    MMW Fortschr Med; 2005 Apr 07; 147(14):14. PubMed ID: 15887675
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S, Rajeev E, Tharakan JA, Titus T, Ajit Kumar VK, Sivasankaran S, Krishnamoorthy KM, Nair K.
    Indian Heart J; 2008 Apr 07; 60(3):215-22. PubMed ID: 19240310
    [Abstract] [Full Text] [Related]

  • 16. Achieving cholesterol goals. Current and future drug therapies.
    Jones PH.
    Postgrad Med; 2003 Aug 07; 114(2 Suppl):14-21. PubMed ID: 19667635
    [Abstract] [Full Text] [Related]

  • 17. Statins in the prevention of transplant coronary artery disease: in pediatric heart recipients.
    Pahl E.
    Pediatr Transplant; 2007 Aug 07; 11(5):459-60. PubMed ID: 17631010
    [No Abstract] [Full Text] [Related]

  • 18. Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes?
    Shepherd J.
    Atheroscler Suppl; 2005 Sep 07; 6(3):15-9. PubMed ID: 16046280
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
    Jones PH.
    Am J Cardiol; 2007 Feb 19; 99(4A):133B-140B. PubMed ID: 17307065
    [Abstract] [Full Text] [Related]

  • 20. Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice.
    Birjmohun RS, Hutten BA, Kastelein JJ, Stroes ES.
    Neth J Med; 2004 Feb 19; 62(7):229-34. PubMed ID: 15554597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.